Patents by Inventor Anthony J. Radford

Anthony J. Radford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnostic assay
    Patent number: 10578612
    Abstract: The present disclosure relates generally to the field of immunological-based diagnostic assays. Particularly, a method is contemplated herein for measuring cell-mediated immune response reactivity. The present disclosure further provides a method to reduce incidence of non-specific immune response reactivity in a cell-mediated immune response-based assay, comprising contacting a sample with a basic peptide structure capable of binding to lipopolysaccharides, such as polymyxin B or a sushi peptide.
    Type: Grant
    Filed: May 23, 2011
    Date of Patent: March 3, 2020
    Assignee: Cellestis International Pty Ltd.
    Inventors: Anthony J. Radford, Emily Manktelow, Jeff Boyle, Jenny Louise Howard
  • Cell-mediated immune response assay and kits therefor
    Patent number: 8871508
    Abstract: The present invention provides methods and kits for measuring a cell-mediated immune (CMI) in a small volume of whole undiluted blood collected from a subject. In particular, the methods are for measuring responses in undiluted whole blood samples having a volume of, for example, 50 ?l to 500 ?l. Thus, capillary sampling and rapid testing of subjects including pediatric, adult or geriatric human subjects are facilitated.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: October 28, 2014
    Assignee: Cellestis Limited
    Inventors: Anthony J. Radford, Stephen L. Jones, Jenny L. Howard
  • DIAGNOSTIC ASSAY
    Publication number: 20130289139
    Abstract: The present disclosure relates generally to the field of immunological-based diagnostic assays. Particularly, a method is contemplated herein for measuring cell-mediated immune response reactivity. The present disclosure further provides a method to reduce incidence of non-specific immune response reactivity in a cell-mediated immune response-based assay, comprising contacting a sample with a basic peptide structure capable of binding to lipopolysaccharides, such as polymyxin B or a sushi peptide.
    Type: Application
    Filed: May 23, 2011
    Publication date: October 31, 2013
    Applicant: CELLESTIS INTERNATIONAL PTY LTD.
    Inventors: Anthony J. Radford, Emily Manktelow, Jeff Boyle, Jenny Louise Howard
  • CELL-MEDIATED IMMUNE RESPONSE ASSAY AND KITS THEREFOR
    Publication number: 20100221712
    Abstract: The present invention provides methods and kits for measuring a cell-mediated immune (CMI) in a small volume of whole undiluted blood collected from a subject. In particular, the methods are for measuring responses in undiluted whole blood samples having a volume of, for example, 50 ?l to 500 ?l. Thus, capillary sampling and rapid testing of subjects including pediatric, adult or geriatric human subjects are facilitated.
    Type: Application
    Filed: March 14, 2008
    Publication date: September 2, 2010
    Inventors: Anthony J. Radford, Stephen L. Jones, Jenny L. Howard
  • Use of a phospholipase D mutant of Corynebacterium pseudotuberculosis for vaccination
    Patent number: 5637303
    Abstract: The present invention relates to a vaccine vector comprising a virulent corynebacterium or related organism which is incapable of expressing an active virulent factor or a non-virulent corynebacterium or related organism which synthesises an immuno protection effective amount of an antigen of a pathogenic organism and its use to stimulate a protective immune response against virulent members of this group.
    Type: Grant
    Filed: April 4, 1995
    Date of Patent: June 10, 1997
    Assignee: Commonwealth Scientific and Industrial Research Organisation
    Inventors: Anthony J. Radford, Adrian L. M. Hodgson
  • Preparation of plasmid DNA and products thereof
    Patent number: 4755464
    Abstract: A method for the preparation of plasmid DNA and the expression products thereof. The method provides cells, enriched in plasmid DNA and expression products thereof, which comprise chromosomal DNA which has been substantially degraded by exposing a plasmid DNA-containing organism to an effective dose of ionizing radiation.
    Type: Grant
    Filed: April 23, 1984
    Date of Patent: July 5, 1988
    Assignee: Gentech Australia Limited
    Inventors: Donald G. MacPhee, Anthony J. Radford, Darryl C. Reanney